<DOC>
	<DOCNO>NCT01298102</DOCNO>
	<brief_summary>In 2009 , pandemic influenza A/H1N1 account worldwide recommendation vaccination . There data concern immunogenicity security adjuvanted-A/H1N1 vaccine renal disease patient . The aim study observe effect vaccine transplant hemodialyzed patient .</brief_summary>
	<brief_title>Influenza A/H1N1/2009-adjuvanted Vaccine Renal Disease Patients</brief_title>
	<detailed_description>The serologic response Pandemrix vaccine ass efficacy , determination seroconversion rate among patient . The anti-HLA anti-MICA antibody determine assess safety among renal transplanted patient .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Adult patient 2 . Haemodialyzed patient 3 . Renal transplant recipient stable renal function last 3 month 1 . No pneumonia severe infection 1 month vaccination 2 . No Ivig ( intravenous immunoglobulin ) treatment last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>kidney</keyword>
	<keyword>transplantation</keyword>
	<keyword>haemodialysis</keyword>
	<keyword>vaccination</keyword>
	<keyword>influenza H1N1 2009</keyword>
</DOC>